Bristol Myers Squibb and RayzeBio, Inc., announced a definitive merger agreement under which Bristol Myers Squibb will acquire RayzeBio for $62.50 per share in...
Atreca, Inc., a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune...
Pacira BioSciences, Inc., the industry leader in its commitment to non-opioid pain management and regenerative health solutions, announced that its Board of Directors (the...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Akron Bio, a leading supplier of critical materials and services...
